These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 36400328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future.
    Rizzo A, Ricci AD, Cusmai A, Acquafredda S, De Palma G, Brandi G, Palmiotti G.
    Curr Oncol; 2022 Jan 27; 29(2):551-564. PubMed ID: 35200550
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
    Chae H, Kim D, Yoo C, Kim KP, Jeong JH, Chang HM, Lee SS, Park DH, Song TJ, Hwang S, Kim KH, Song GW, Ahn CS, Lee JH, Hwang DW, Kim SC, Jang SJ, Hong SM, Kim TW, Ryoo BY.
    Eur J Cancer; 2019 Oct 27; 120():31-39. PubMed ID: 31476489
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma.
    Tella SH, Mahipal A.
    Expert Opin Pharmacother; 2022 Dec 27; 23(17):1879-1885. PubMed ID: 36257911
    [Abstract] [Full Text] [Related]

  • 8. Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
    Roth GS, Neuzillet C, Sarabi M, Edeline J, Malka D, Lièvre A.
    Eur J Cancer; 2023 Jan 27; 179():1-14. PubMed ID: 36463640
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy in Biliary Tract Cancers: Where Are We?
    Kalyan A, Khosla H, Kim RD.
    Curr Oncol Rep; 2022 Dec 27; 24(12):1821-1828. PubMed ID: 36192517
    [Abstract] [Full Text] [Related]

  • 10. Current and emerging therapies for advanced biliary tract cancers.
    Kam AE, Masood A, Shroff RT.
    Lancet Gastroenterol Hepatol; 2021 Nov 27; 6(11):956-969. PubMed ID: 34626563
    [Abstract] [Full Text] [Related]

  • 11. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.
    Ten Haaft BH, Pedregal M, Prato J, Klümpen HJ, Moreno V, Lamarca A.
    Eur J Cancer; 2024 Mar 27; 199():113564. PubMed ID: 38266541
    [Abstract] [Full Text] [Related]

  • 12. Cholangiocellular Carcinoma.
    Vogel A, Saborowski A.
    Digestion; 2017 Mar 27; 95(3):181-185. PubMed ID: 28288474
    [Abstract] [Full Text] [Related]

  • 13. Molecular targeted therapies: Ready for "prime time" in biliary tract cancer.
    Lamarca A, Barriuso J, McNamara MG, Valle JW.
    J Hepatol; 2020 Jul 27; 73(1):170-185. PubMed ID: 32171892
    [Abstract] [Full Text] [Related]

  • 14. Novel precision therapies for cholangiocarcinoma: an overview of clinical trials.
    Uson Junior PLS, Bearss J, Babiker HM, Borad MJ.
    Expert Opin Investig Drugs; 2023 Jan 27; 32(1):69-75. PubMed ID: 36714945
    [Abstract] [Full Text] [Related]

  • 15. Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.
    Athauda A, Fong C, Lau DK, Javle M, Abou-Alfa GK, Morizane C, Steward K, Chau I.
    Cancer Treat Rev; 2020 Jun 27; 86():101998. PubMed ID: 32203843
    [Abstract] [Full Text] [Related]

  • 16. [Not Available].
    Valéry M, Cervantes B, Smolenschi C, Boige V, Ducreux M, Cohen R, Hollebecque A.
    Bull Cancer; 2022 Nov 27; 109(11S):11S21-11S27. PubMed ID: 36535759
    [Abstract] [Full Text] [Related]

  • 17. The state of therapy modalities in clinic for biliary tract cancer.
    Chen W, Hu Z, Song J, Wu Y, Zhang B, Zhang L.
    Front Biosci (Landmark Ed); 2022 Jun 08; 27(6):185. PubMed ID: 35748261
    [Abstract] [Full Text] [Related]

  • 18. Facts and Hopes in the Systemic Therapy of Biliary Tract Carcinomas.
    Lamarca A, Macarulla T.
    Clin Cancer Res; 2024 Sep 03; 30(17):3688-3696. PubMed ID: 38934628
    [Abstract] [Full Text] [Related]

  • 19. Systemic treatment options for advanced biliary tract carcinoma.
    Xie C, McGrath NA, Monge Bonilla C, Fu J.
    J Gastroenterol; 2020 Oct 03; 55(10):944-957. PubMed ID: 32748173
    [Abstract] [Full Text] [Related]

  • 20. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.
    Neuzillet C, Artru P, Assenat E, Edeline J, Adhoute X, Sabourin JC, Turpin A, Coriat R, Malka D.
    Target Oncol; 2023 Jan 03; 18(1):51-76. PubMed ID: 36745342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.